Published in J Biol Chem on January 24, 2007
Identification and characterization of nucleolin as a c-myc G-quadruplex-binding protein. J Biol Chem (2009) 1.72
Targeting MYC Expression through G-Quadruplexes. Genes Cancer (2010) 1.29
DNA and RNA quadruplex-binding proteins. Int J Mol Sci (2014) 1.01
Phosphorylated nucleolin interacts with translationally controlled tumor protein during mitosis and with Oct4 during interphase in ES cells. PLoS One (2010) 0.85
A novel post-translational modification of nucleolin, SUMOylation at Lys-294, mediates arsenite-induced cell death by regulating gadd45α mRNA stability. J Biol Chem (2015) 0.84
Stat1 nuclear translocation by nucleolin upon monocyte differentiation. PLoS One (2009) 0.83
Exploring the RNA world in hematopoietic cells through the lens of RNA-binding proteins. Immunol Rev (2013) 0.80
Control of AC133/CD133 and impact on human hematopoietic progenitor cells through nucleolin. Leukemia (2015) 0.76
Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients. PLoS One (2017) 0.75
The Arabidopsis hnRNP-Q Protein LIF2 and the PRC1 subunit LHP1 function in concert to regulate the transcription of stress-responsive genes. Plant Cell (2016) 0.75
A mammalian microRNA expression atlas based on small RNA library sequencing. Cell (2007) 34.03
Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation (2002) 7.14
A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med (2004) 4.37
Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J Am Coll Cardiol (2005) 3.72
Small molecules enable highly efficient neuronal conversion of human fibroblasts. Nat Methods (2012) 2.64
Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell (2007) 1.87
Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J Immunol (2002) 1.74
Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor. Haematologica (2008) 1.74
Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cells. Blood (2004) 1.67
Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. Exp Hematol (2005) 1.63
HLA class I/II matching and chronic endothelial cell loss in penetrating normal risk keratoplasty. Acta Ophthalmol Scand (2004) 1.56
MicroRNAs MiR-17, MiR-20a, and MiR-106b act in concert to modulate E2F activity on cell cycle arrest during neuronal lineage differentiation of USSC. PLoS One (2011) 1.40
Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics (2002) 1.37
Asymmetric cell division within the human hematopoietic stem and progenitor cell compartment: identification of asymmetrically segregating proteins. Blood (2007) 1.34
Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells. BMC Res Notes (2010) 1.32
Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition. Blood (2010) 1.28
Unrelated cord blood transplants in adults with hematologic malignancies. Haematologica (2006) 1.27
Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency. Ophthalmology (2004) 1.23
Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1. Blood (2004) 1.23
Conservation and variation in human and common chimpanzee CD94 and NKG2 genes. J Immunol (2002) 1.21
Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor. J Immunol (2007) 1.20
Bortezomib/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells. Cell Signal (2012) 1.14
Sp1 as G1 cell cycle phase specific transcription factor in epithelial cells. Oncogene (2002) 1.12
The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells. J Exp Med (2004) 1.11
Comparative generation and characterization of pluripotent unrestricted somatic stem cells with mesenchymal stem cells from human cord blood. Exp Hematol (2006) 1.08
Induction of pluripotency in human cord blood unrestricted somatic stem cells. Exp Hematol (2010) 1.06
Tracing the pre-B to immature B cell transition in human leukemia cells reveals a coordinated sequence of primary and secondary IGK gene rearrangement, IGK deletion, and IGL gene rearrangement. J Immunol (2005) 1.05
Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3. J Immunol (2005) 1.05
T lymphoid differentiation in human bone marrow. Proc Natl Acad Sci U S A (2003) 1.03
Primitive human hematopoietic cells give rise to differentially specified daughter cells upon their initial cell division. Blood (2005) 1.02
Rapid and highly efficient gene transfer into natural killer cells by nucleofection. J Immunol Methods (2003) 1.02
Molecular characterization of KIR3DL3. Immunogenetics (2006) 1.00
Neonatal NK-cell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I. Blood (2011) 1.00
Cellular signaling in normal and cancerous stem cells. Cell Signal (2007) 1.00
KIR expression shapes cytotoxic repertoires: a developmental program of survival. Trends Immunol (2002) 1.00
Nucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancer. J Exp Med (2002) 0.98
Epigenetic silencing of potentially functional KIR2DL5 alleles: Implications for the acquisition of KIR repertoires by NK cells. Eur J Immunol (2007) 0.98
DLK-1 as a marker to distinguish unrestricted somatic stem cells and mesenchymal stromal cells in cord blood. Stem Cells Dev (2010) 0.97
Nucleofection, an efficient nonviral method to transfer genes into human hematopoietic stem and progenitor cells. Stem Cells Dev (2006) 0.96
MicroRNA-based promotion of human neuronal differentiation and subtype specification. PLoS One (2013) 0.95
Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells. Proc Natl Acad Sci U S A (2005) 0.95
The HOX Code as a "biological fingerprint" to distinguish functionally distinct stem cell populations derived from cord blood. Stem Cell Res (2010) 0.94
Lineage-specific transition of histone signatures in the killer cell Ig-like receptor locus from hematopoietic progenitor to NK cells. J Immunol (2008) 0.92
Cell cycle-controlled interaction of nucleolin with the retinoblastoma protein and cancerous cell transformation. J Biol Chem (2006) 0.92
IL-15 induces CD8+ T cells to acquire functional NK receptors capable of modulating cytotoxicity and cytokine secretion. Immunobiology (2010) 0.91
The role of KIR genes and ligands in leukemia surveillance. Front Immunol (2013) 0.91
Unrestricted somatic stem cells from human umbilical cord blood can be differentiated into neurons with a dopaminergic phenotype. Stem Cells Dev (2008) 0.90
Transplantation of human umbilical cord blood-derived adherent progenitors into the developing rodent brain. J Neuropathol Exp Neurol (2005) 0.90
Induction of indoleamine 2, 3-dioxygenase by death receptor activation contributes to apoptosis of melanoma cells via mitochondrial damage-dependent ROS accumulation. Cell Signal (2009) 0.89
Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands. Hum Immunol (2003) 0.88
Unrestricted somatic stem cells (USSC) from human umbilical cord blood display uncommitted epigenetic signatures of the major stem cell pluripotency genes. Stem Cell Res (2010) 0.88
Cellular immunity of patients with malignant glioma: prerequisites for dendritic cell vaccination immunotherapy. J Neurosurg (2006) 0.88
Histone methyltransferase enhancer of zeste homolog 2 regulates Schwann cell differentiation. Glia (2012) 0.85
Clinical-scale generation of dendritic cells in a closed system. J Immunother (2003) 0.85
Network-like impact of MicroRNAs on neuronal lineage differentiation of unrestricted somatic stem cells from human cord blood. Stem Cells Dev (2011) 0.85
Lack of association between KIR genes and acute lymphoblastic leukemia in children. Blood (2012) 0.84
CD8 T-cell subsets and viral load in the cerebrospinal fluid of therapy-naive HIV-infected individuals. AIDS (2007) 0.84
HLA class I and II matching improves prognosis in penetrating normal-risk keratoplasty. Dev Ophthalmol (2003) 0.84
The impact of HLA-C matching depends on the C1/C2 KIR ligand status in unrelated hematopoietic stem cell transplantation. Immunogenetics (2012) 0.83
MicroRNAs miR-26a, miR-26b, and miR-29b accelerate osteogenic differentiation of unrestricted somatic stem cells from human cord blood. BMC Genomics (2013) 0.83
Hepatocytes and IL-15: a favorable microenvironment for T cell survival and CD8+ T cell differentiation. J Immunol (2009) 0.83
Suppression of cellular immunity by cord blood-derived unrestricted somatic stem cells is cytokine-dependent. J Cell Mol Med (2008) 0.82
T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecific tetravalent antibody CD19 × CD3 or CD19 × CD16. Cancer Immunol Immunother (2012) 0.82
Hepatocyte growth factor/c-MET axis-mediated tropism of cord blood-derived unrestricted somatic stem cells for neuronal injury. J Biol Chem (2008) 0.81
Recipient cytokine genotypes for TNF-alpha and IL-10 and the minor histocompatibility antigens HY and CD31 codon 125 are not associated with occurrence or severity of acute GVHD in unrelated cord blood transplantation: a retrospective analysis. Transplantation (2002) 0.79
Vinblastine-induced apoptosis of melanoma cells is mediated by Ras homologous A protein (Rho A) via mitochondrial and non-mitochondrial-dependent mechanisms. Apoptosis (2013) 0.79
Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis. Mult Scler (2011) 0.78
Delivery of DNA into natural killer cells for immunotherapy. Methods Mol Biol (2008) 0.78
Superior mobilisation of haematopoietic progenitor cells with glycosylated G-CSF in male but not female unrelated stem cell donors. Br J Haematol (2005) 0.78
Direct and quantitative analysis of chromatin accessibility by MIRECAL--a Micrococcus nuclease/real-time PCR chromatin accessibility assay with locus specificity. Anal Biochem (2006) 0.77
[Transplantation of autologous adult bone marrow stem cells in patients with severe peripheral arterial occlusion disease]. Med Klin (Munich) (2006) 0.77
Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantation. Biol Blood Marrow Transplant (2010) 0.76
Placental/umbilical cord blood for unrelated-donor bone marrow reconstitution: relevance of nucleated red blood cells. Blood (2002) 0.76
Prevention of leukemia relapse by donor activating KIR2DS1. N Engl J Med (2012) 0.76
[Rapid healing of a therapy-refractory diabetic foot after transplantation of autologous bone marrow stem cells]. Med Klin (Munich) (2005) 0.76
Genome-wide screening identifies Plasmodium chabaudi-induced modifications of DNA methylation status of Tlr1 and Tlr6 gene promoters in liver, but not spleen, of female C57BL/6 mice. Parasitol Res (2013) 0.75
Non-viral gene delivery into primary natural killer lymphocytes. FASEB J (2006) 0.75
Protocol for the clonal analysis of NK cell effector functions by multi-parameter flow cytometry. Methods Mol Biol (2012) 0.75
[Stem cell therapy in acute myocardial infarction]. Med Klin (Munich) (2003) 0.75